2) Experimental Procedures a. Synthesis of 2-OH thioglucosides 6-9 applying the orthoester strategy
1) General Remarks
All reactions were performed under an argon atmosphere. Anhydrous solvents were obtained using a PURESOLV system of it-innovative technology. Molecular sieves (3Å) were activated before use by heating at 200 °C under vacuum. Analytical thin layer chromatography (TLC) was performed using plates cut from aluminum sheets (silica gel 60 F-254). Visualization was achieved under a 254 nm or 365 nm UV light and by immersion in a solution of ceric ammonium molybdate in ethanol/sulfuric acid followed by heating with a heat gun. Chromatographic separation was carried out on a 3000 series HPLC-UV system (Dionex UltiMate 3000, Thermo Scientific) using a Chiralpak IB column (Cellulose tris-(3,5-dimethylphenylcarbamate) immobilized on 5 µm silica-gel, 4.6x250mm, Chiral Technologies Europe) and n-heptane/iPrOH gradient elution (flow rate: 1 mL/min, 0-4 min: 4% iPrOH, 4-25 min: 4 to 20% iPrOH linear gradient, 25-30 min: 20% iPrOH, 30-30.1 min: 20 to 4% iPrOH linear gradient, 30.1-35 min: 4% iPrOH). Preparative column chromatography was performed on a Büchi Sepacore Flash System (2 x Büchi Pump Module C-605, Büchi Pump Manager C-615, Büchi UV Photometer C-635, Büchi Fraction Collector C-660) or a Grace Reveleris Prep Purification System using silica gel 60 (40-63 μm) as obtained from Merck and distilled solvents. 1 H and 13 C NMR spectra were recorded on a Bruker DPX 200-MHz, an Avance DRX-400 MHz or an Avance IIIHD 600-MHz spectrometer equipped with a Prodigy BBO cryo probe (Bruker, Germany). Data were recorded and evaluated using TOPSPIN 3.5 (Bruker Biospin). Chemical shifts are reported in ppm (δ) relative to tetramethylsilane and calibrated using solvent residual peaks. Multiplicities are abbreviated as s (singlet), d (doublet), t (triplet), q (quartet), b (broad signal). All chemicals were purchased either from ABCR (Germany) or Sigma-Aldrich (Austria/Germany). HR-MS analysis was carried out from methanol solutions (concentration: 10 ppm) by using an HTC PAL system autosampler (CTC Analytics AG, Zwingen, Switzerland), an Agilent 1100/1200 HPLC with binary pumps, degasser and column thermostat (Agilent Technologies, Waldbronn, Germany) and Agilent 6230 AJS ESI-TOF mass spectrometer (Agilent Technologies, Palo Alto, United States). 3,4,6-Tri-O-benzyl-1,2-O-(1-ethylthioethylidene)-α-Dglucopyranose (1) [1] , dimethyldioxirane (DMDO) [2] , methyl 2,3,4-tri-O-benzyl-1-O-β-D-glucopyranoside (20) [3] [4] [5] , and methyl 2,3,6-tri-O-benzyl-1-O-β-D-glucopyranoside (22) [6] were synthesized following known procedures. 3 was obtained as a white solid (2.40 g, 80%); Rf 0.64 (hexanes/EtOAc = 3/1); 1 data matched that reported. [7] 
1,3-Thiazolin-2-yl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucoside (4)
4 was obtained as a white solid (2.13 g, 72%); Rf 0.40 (hexanes/EtOAc = 3/2); 1 ), 20.9 (q, 1C); NMR data matched that reported. [8] 
2-Pyrimidyl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucoside (5):
5 was obtained as a yellowish solid (2.12 g, 72%); Rf 0.44 (hexanes/EtOAc = 3/2); 1 
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General procedure for de-acetylation of 2-OAc thioglucosides. To a solution/suspension of the 2-OAc thioglucoside (1 mmol) in dry MeOH (5 mL) K2CO3 (28 mg, 0.2 mmol) was added and the reaction mixture was stirred at room temperature until the starting material had completely dissolved (up to 72 h). The reaction mixture was quenched by addition of acidic cation exchange resin (Amberlite ® IR120H), filtrated and concentrated under reduced pressure. The residue was purified by column chromatography (hexanes/EtOAc gradient elution + 0.1% NEt3) to obtain the desired product. 
c. Introduction of benzyloxycarbonyl (Cbz) at O-2
General procedure. To a solution of the 2-OH thioglucoside (0.5 mmol) in dry CH2Cl2 (5 mL), cooled to 0 °C, TMEDA (58 mg, 0.5 mmol) was added, followed by Cbz-Cl (127 mg, 0.75 mmol). The reaction mixture was stirred for 48 h, poured into water (20 mL) and extracted with CH2Cl2. The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography (hexanes/EtOAc gradient elution) to yield the desired Cbz-protected thioglucoside.
Ethyl 3,4,6-tri-O-benzyl-2-O-benzyloxycarbonyl-1-thio-β-D-glucoside (11)
11 was obtained as a white solid (420 mg, 45%); Rf 0.42 (hexanes/EtOAc = 6/1); 1 
e. Glycosylation reactions (analytical and preparative) General procedure for glycosylation reactions with thioglucosyl donors
To a solution of the glucosyl donor (0.05 mmol) and the acceptor (0.05 or 0.075 mmol) in dry CH2Cl2 (1 mL) molecular sieve (3Å, 100 mg) was added and the reaction mixture was stirred for 14 h at room temperature.
After cooling to the appropriate temperature, activator (see Table S1 ) was added and stirring was continued in the dark for 24 h. Samples of the reaction mixture (100 µl) were taken after 3 h and 24 h and diluted with 1.9 mL CH2Cl2. To quench the reaction, the solution was washed with 1 mL of aqueous saturated NaHCO3 or Na2SO3 solution, and 0.5 mL water. The organic layer was separated, dried over Na2SO4 and concentrated. The residue was diluted in 3 mL acetonitrile and 1 mL was taken and filtered through a syringe filter. This sample was analyzed by HPLC-UV using previously isolated material as a reference (external and internal calibration).
General procedure for glycosylation reactions with N-phenyltrifluoroacetimidoyl glucosyl donor
To a solution of the glucosyl donor (0.03 mmol) and the acceptor (0.05-0.06 mmol) in dry CH2Cl2 (2 mL) molecular sieve (3Å, 100 mg) was added and the reaction mixture was stirred for 2 h at room temperature.
After cooling to the appropriate temperature, activator (see Table S1 ) was added and stirring was continued for 2 h. The reaction was quenched by addition of NEt3. A sample of the reaction mixture (100 µl) was taken, diluted with 0.9 mL MeCN and filtered through a syringe filter. This sample was then analyzed by HPLC-UV using isolated material as a reference (external and internal calibration). 
2-Phenylethyl 3,4,6-tri-O-benzyl-2-O-benzyloxycarbonyl-β-D-glucopyranoside (24)
To 
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f. Deprotection
2-Phenylethyl-β-D-glucopyranoside (29)
To a suspension of compound 24 (20 mg, 0.03 mmol) in dry ethanol (1 mL) one small tip of a spatula of Pd/C was added under an argon atmosphere. The argon balloon was changed for a balloon filled with H2 and the reaction mixture was stirred for 4 h at rt. The reaction mixture was filtered through a syringe filter and the filtrate was concentrated. The residue was dissolved in water and purified by preparative HPLC to yield 29 as a white solid (7 mg, 87%). The obtained material was identical with reference material of 29 previously prepared using a known procedure for Königs-Knorr glucosylation of 2-phenylethanol. [11] 
1,2,3,4-Tetra-O-acetyl-gentiobioside (30)
To a suspension of disaccharide 26 (50 mg, 0.05 mmol) in dry ethanol (3 mL) two small tips of a spatula of Pd/C were added under an argon atmosphere.
The argon balloon was changed for a balloon filled with a H2 and the mixture was stirred for 1 h at rt. The reaction mixture was filtered through a syringe filter and the filtrate was concentrated. The residue was dissolved in water and purified by preparative HPLC to yield 28 as a white solid (20 mg, 71%). 1 Water was added and the reaction mixture was concentrated to a third of its volume. The residue was diluted with MeCN/H2O (1:1) and purified by preparative HPLC to obtain compound 31, as an anomeric mixture (50 mg, 75 %). 1 
g. Synthesis of glycosyl esters trans-N-(tert-butoxycarbonyl)-4-acetoxy-L-proline (32)
The title compound was prepared according to a procedure described by Wong [12] and obtained as a white solid (588 mg, 99%); 1 
trans-N-(tert-butoxycarbonyl)-4-acetoxy-L-proline, 3,4,6-tri-O-benzyl-2-O-benzyloxycarbonyl-β-Dglucopyranosyl ester (33)
To a solution of glucosyl donor 11 (100 mg, 0.16 mmol) and trans-N-(tertbutoxycarbonyl)-4-acetoxy-L-proline (65 mg, 0.24 mmol) in dry CH2Cl2 (3 mL) molecular sieve 3Å (150 mg) was added and the reaction mixture was stirred for 2 h at room temperature. After cooling to -10°C, NIS (72 mg, 0.32 mmol) and TfOH (5 mg, 0.03 mmol) were added and stirring was continued for 2 h at -10 °C. The reaction was quenched by addition of an aqueous saturated NaHCO3 and Na2SO3 solution 
trans-N-(tert-butoxycarbonyl)-4-acetoxy-L-proline, ß-D-glucopyranosyl ester (34)
To a suspension of compound 33 (71 mg, 0.085 mmol) in dry ethanol (1.5 mL) were added two small tips of a spatula of Pd/C under argon atmosphere. The argon balloon was changed for a balloon filled with a H2 and the reaction mixture was stirred at rt for 16 h. The reaction mixture was filtered through a syringe filter and concentrated. The residue was dissolved in a mixture of MeCN/H2O and purified by preparative HPLC to yield 32 as a white solid (30 mg, 81%). 1H NMR (600 MHz, MeOD) δ 5.50 
Acetylsalicylic acid, 3,4,6-tri-O-benzyl-2-O-benzyloxycarbonyl-β-D-glucopyranosyl ester (36)
To a solution of glucosyl donor 11 (100 mg, 0.16 mmol) and acetylsalicylic acid (33) (43 mg, 0.24 mmol) in dry CH2Cl2 (3 mL) molecular sieve 3Å (150 mg) was added and the reaction mixture was stirred for 2 h at room temperature. After cooling to -10°C, NIS (72 mg, 0.32 mmol) and TfOH (5 mg, 0.03 mmol) were added and stirring was continued for 2 h at -10 °C. The reaction was quenched by addition of an aqueous saturated NaHCO3 and Na2SO3 solution (1:1). The mixture was diluted with CH2Cl2 and filtrated over Celite. The filtrate was washed with water and brine, dried over Na2SO4 and concentrated. The residue was purified by column chromatography (hexanes/EtOAc gradient elution) to obtain the desired product 34 (100 mg, 84%); Rf 0.67 (hexanes/EtOAc = 2/1); 1 
3) NMR Spectra
